RecruitingPhase 2Phase 3NCT06598033

Vitamin C Plus Cordyceps to Quality of Life in Patients With Terminal Stage Pancreatic Cancer


Sponsor

Fudan University

Enrollment

50 participants

Start Date

Nov 22, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The purpose of this study is to evaluate the efficacy of vitamin C plus herbal medicine in improving the quality of life for metastatic pancreatic cancer patients who are resistant to chemotherapy.


Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This study is testing whether a combination of high-dose Vitamin C and a supplement called Cordyceps (a medicinal mushroom extract) can improve quality of life for patients with end-stage (terminal) pancreatic cancer who have already received two lines of standard treatment. **You may be eligible if...** - You are between 18 and 80 years old - You have confirmed metastatic pancreatic adenocarcinoma (confirmed by biopsy) - Your cancer has progressed after at least two lines of treatment - You have good enough organ function - You have at least one measurable tumor on imaging - Your expected survival is at least 1 month **You may NOT be eligible if...** - Your cancer is not adenocarcinoma (a different type of pancreatic cancer) - You have active digestive tract inflammation (pancreatitis, cholecystitis, etc.) - You are pregnant or nursing - You have G6PD enzyme deficiency (a genetic blood condition) - You have kidney failure or are on dialysis - You have other serious medical conditions Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGVC plus herbal medicine

Vitamin C 300 mg/day, TID, PO. Reishi, 2 g/day, BID, PO. Cordyceps, 2 g/day, BID, PO.


Locations(1)

Shanghai Cancer Center

Shanghai, China

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06598033


Related Trials